Zokinvy
A monthly supply of Zokinvy can cost around $89,000 and upwards of $1 million for a year.
Taken as a pill, Zokinvy was approved in 2020 as the first specialized treatment for Hutchinson-Gilford progeria syndrome, a rare genetic condition that prematurely ages the body (most people with it die before age 15). It reduces the build-up of progerin, a defective protein that plays a key role in the condition. In trials, the drug extended people’s lives by an average 2.5 years.
